As of March, Public Health Canada’s COVID-19 vaccination program included Moderna, Pfizer-BioNTech, AstraZeneca, and most recently the Janssen (Johnson & Johnson) vaccines. The campaign, which started in December 2020, is expected to ramp up in the coming months.
As of March 24, Canada administered more than 4.3 million vaccines across the country.
According to data from the Government of Canada, approximately 2.5 million Canadians or 6.8 per cent Canada’s population has received at least one dose of the approved COVID-19 vaccines.
As Canada continues to receive more vaccine doses from the pharmaceutical companies, it is expected more Canadians will be able to get vaccinated.
Canada is currently in Stage 1 of its three-staged vaccination timeline. COVID-19 vaccinations are offered to groups of Canadians who are at higher risk of severe outcomes related to the virus including residents and staff at senior long-term care homes, adults aged 70, older frontline health care workers, and adults in Indigenous communities.
When enough COVID-19 vaccines and supplies become available, Public Health Canada will begin offering vaccinations to Stage 2 groups (including adults 60 to 69 years of age) and Stage 3 groups (the rest of the population).
Currently, Canada is on track to vaccinate 8 per cent of the total population by the end of March with the remaining population expected to receive their vaccines starting at the beginning of this month as per the government’s COVID-19 immunization timeline.
This content is also available in: Tiếng Việt